Exact Mass: 627.3288

Exact Mass Matches: 627.3288

Found 14 metabolites which its exact mass value is equals to given mass value 627.3288, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Boc-val-pro-arg-mca

tert-butyl N-{1-[2-({4-[(diaminomethylidene)amino]-1-[(4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl]butyl}carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

C31H45N7O7 (627.338)


   
   

GAMBOGIC ACID AMIDE

GAMBOGIC ACID AMIDE

C38H45NO7 (627.3196)


   

Tetrabenzyl voglibose

Tetrabenzyl voglibose

C38H45NO7 (627.3196)


   

5-Hydroxy-6-S-glutathionyl-7,9,11-eicosatrienoic acid

5-Hydroxy-6-S-glutathionyl-7,9,11-eicosatrienoic acid

C30H49N3O9S (627.3189)


   

[(2R,3S,4R,5R,6R)-3-hydroxy-5-[[(3R)-3-hydroxydodecanoyl]amino]-2-(hydroxymethyl)-6-phosphonooxyoxan-4-yl] (3R)-3-hydroxydecanoate

[(2R,3S,4R,5R,6R)-3-hydroxy-5-[[(3R)-3-hydroxydodecanoyl]amino]-2-(hydroxymethyl)-6-phosphonooxyoxan-4-yl] (3R)-3-hydroxydecanoate

C28H54NO12P (627.3383)


   
   

SHexCer 10:0;2O/12:1;O

SHexCer 10:0;2O/12:1;O

C28H53NO12S (627.3288)


   

SHexCer 10:1;2O/12:0;O

SHexCer 10:1;2O/12:0;O

C28H53NO12S (627.3288)


   

leukotriene C3

leukotriene C3

C30H49N3O9S (627.3189)


A leukotriene that is (5S,7E,9E,11Z)-5-hydroxyicosa-7,9,11-trienoic acid in which a glutathionyl group is attached at position 6 via a sulfide linkage.

   

ST 23:2;O7;HexNAc

ST 23:2;O7;HexNAc

C31H49NO12 (627.3255)


   

Gambogic amide

Gambogic amide

C38H45NO7 (627.3196)


Gambogic amide is a potent and selective agonist of TrkA and also induces its tyrosine phosphorylation and activation of downstream signaling, including Akt and MAPK. Gambogic amide specifically interacts with the cytoplasmic juxtamembrane domain of the TrkA receptor and triggers its dimerization, leading to activation. Gambogic amide has neuroprotective activity preventing glutamate-induced neuronal cell death. Gambogic amide has improved efficacy in a transient middle cerebral artery occlusion model of stroke and could be used to study neurodegenerative diseases and stroke[1].

   

(1s,11s,12r,13r,14e,16s,19s,21s)-10-{3-ethyl-8-methoxy-6h,7h-indolo[2,3-a]quinolizin-2-yl}-11-hydroxy-14-(2-hydroxyethylidene)-16-methyl-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,9-tetraen-16-ium

(1s,11s,12r,13r,14e,16s,19s,21s)-10-{3-ethyl-8-methoxy-6h,7h-indolo[2,3-a]quinolizin-2-yl}-11-hydroxy-14-(2-hydroxyethylidene)-16-methyl-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,9-tetraen-16-ium

[C40H43N4O3]+ (627.3335)


   

(1s,11s,12r,13r,14z,19s,21s)-10-{3-ethyl-8-methoxy-6h,7h-indolo[2,3-a]quinolizin-2-yl}-11-hydroxy-14-(2-hydroxyethylidene)-16-methyl-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,9-tetraen-16-ium

(1s,11s,12r,13r,14z,19s,21s)-10-{3-ethyl-8-methoxy-6h,7h-indolo[2,3-a]quinolizin-2-yl}-11-hydroxy-14-(2-hydroxyethylidene)-16-methyl-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,9-tetraen-16-ium

[C40H43N4O3]+ (627.3335)